Celldex Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
CLDX
CUSIP
15117B202
Type
Equity
Class
COM NEW
Num filers
202
Total reported value, excl. options
$2.91B
Manager Report Date Value ($000) Shares